Cardiovascular Toxicology delves into the intricate study of the detrimental effects of various compounds on the cardiovascular system. This specialized field integrates principles from pharmacology, toxicology, and cardiology to unravel the impact of drugs, chemicals, and environmental factors on the heart and blood vessels. Experts in cardiovascular toxicology strive to uncover and evaluate potential risks associated with exposure to specific substances, especially those prevalent in medications, industrial processes, or everyday surroundings. By delving into the underlying mechanisms through which these agents influence cardiovascular function, researchers contribute essential knowledge to the development of safer pharmaceuticals, environmental policies, and occupational safety standards. The overarching aim of cardiovascular toxicology is to deepen our comprehension of cardiovascular health, diminish potential hazards, and advance preventive measures against cardiovascular-related diseases.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation